nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—Drug interaction—Vincristine—muscle cancer	0.024	0.024	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Vincristine—muscle cancer	0.0225	0.0225	CcSEcCtD
Hydrocodone—Lethargy—Dactinomycin—muscle cancer	0.0184	0.0184	CcSEcCtD
Hydrocodone—Deafness—Vincristine—muscle cancer	0.0181	0.0181	CcSEcCtD
Hydrocodone—Pain in extremity—Vincristine—muscle cancer	0.0162	0.0162	CcSEcCtD
Hydrocodone—Urinary retention—Vincristine—muscle cancer	0.0154	0.0154	CcSEcCtD
Hydrocodone—Dehydration—Vincristine—muscle cancer	0.015	0.015	CcSEcCtD
Hydrocodone—Agranulocytosis—Dactinomycin—muscle cancer	0.013	0.013	CcSEcCtD
Hydrocodone—Connective tissue disorder—Vincristine—muscle cancer	0.011	0.011	CcSEcCtD
Hydrocodone—Angiopathy—Vincristine—muscle cancer	0.0101	0.0101	CcSEcCtD
Hydrocodone—Mediastinal disorder—Vincristine—muscle cancer	0.0101	0.0101	CcSEcCtD
Hydrocodone—Mental disorder—Vincristine—muscle cancer	0.00979	0.00979	CcSEcCtD
Hydrocodone—Neck pain—Doxorubicin—muscle cancer	0.00946	0.00946	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00946	0.00946	CcSEcCtD
Hydrocodone—Agranulocytosis—Etoposide—muscle cancer	0.00941	0.00941	CcSEcCtD
Hydrocodone—Back pain—Vincristine—muscle cancer	0.00941	0.00941	CcSEcCtD
Hydrocodone—Myalgia—Dactinomycin—muscle cancer	0.00927	0.00927	CcSEcCtD
Hydrocodone—Thrombocytopenia—Dactinomycin—muscle cancer	0.0087	0.0087	CcSEcCtD
Hydrocodone—Convulsion—Vincristine—muscle cancer	0.00843	0.00843	CcSEcCtD
Hydrocodone—Myalgia—Vincristine—muscle cancer	0.00828	0.00828	CcSEcCtD
Hydrocodone—Angiopathy—Etoposide—muscle cancer	0.00821	0.00821	CcSEcCtD
Hydrocodone—Mediastinal disorder—Etoposide—muscle cancer	0.00816	0.00816	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.0081	0.0081	CcSEcCtD
Hydrocodone—Lethargy—Methotrexate—muscle cancer	0.008	0.008	CcSEcCtD
Hydrocodone—Osteoarthritis—Methotrexate—muscle cancer	0.00784	0.00784	CcSEcCtD
Hydrocodone—Nervous system disorder—Vincristine—muscle cancer	0.00779	0.00779	CcSEcCtD
Hydrocodone—Thrombocytopenia—Vincristine—muscle cancer	0.00777	0.00777	CcSEcCtD
Hydrocodone—Hyperhidrosis—Vincristine—muscle cancer	0.00767	0.00767	CcSEcCtD
Hydrocodone—Fatigue—Dactinomycin—muscle cancer	0.00766	0.00766	CcSEcCtD
Hydrocodone—Back pain—Etoposide—muscle cancer	0.00762	0.00762	CcSEcCtD
Hydrocodone—Muscle spasms—Etoposide—muscle cancer	0.00758	0.00758	CcSEcCtD
Hydrocodone—Mood swings—Methotrexate—muscle cancer	0.00742	0.00742	CcSEcCtD
Hydrocodone—Hypotension—Vincristine—muscle cancer	0.00742	0.00742	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00727	0.00727	CcSEcCtD
Hydrocodone—Hot flush—Doxorubicin—muscle cancer	0.00725	0.00725	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00723	0.00723	CcSEcCtD
Hydrocodone—Menopausal symptoms—Doxorubicin—muscle cancer	0.00719	0.00719	CcSEcCtD
Hydrocodone—Insomnia—Vincristine—muscle cancer	0.00718	0.00718	CcSEcCtD
Hydrocodone—Paraesthesia—Vincristine—muscle cancer	0.00713	0.00713	CcSEcCtD
Hydrocodone—Abdominal pain—Dactinomycin—muscle cancer	0.00702	0.00702	CcSEcCtD
Hydrocodone—Body temperature increased—Dactinomycin—muscle cancer	0.00702	0.00702	CcSEcCtD
Hydrocodone—Lethargy—Doxorubicin—muscle cancer	0.00693	0.00693	CcSEcCtD
Hydrocodone—Cough—Etoposide—muscle cancer	0.00688	0.00688	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Vincristine—muscle cancer	0.00685	0.00685	CcSEcCtD
Hydrocodone—Fatigue—Vincristine—muscle cancer	0.00684	0.00684	CcSEcCtD
Hydrocodone—Convulsion—Etoposide—muscle cancer	0.00683	0.00683	CcSEcCtD
Hydrocodone—Constipation—Vincristine—muscle cancer	0.00679	0.00679	CcSEcCtD
Hydrocodone—Osteoarthritis—Doxorubicin—muscle cancer	0.00679	0.00679	CcSEcCtD
Hydrocodone—Pain in extremity—Doxorubicin—muscle cancer	0.00679	0.00679	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—muscle cancer	0.00668	0.00668	CcSEcCtD
Hydrocodone—Migraine—Doxorubicin—muscle cancer	0.00668	0.00668	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00666	0.00666	CcSEcCtD
Hydrocodone—Hypersensitivity—Dactinomycin—muscle cancer	0.00655	0.00655	CcSEcCtD
Hydrocodone—Abdominal discomfort—Methotrexate—muscle cancer	0.00649	0.00649	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Vincristine—muscle cancer	0.00649	0.00649	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—muscle cancer	0.00643	0.00643	CcSEcCtD
Hydrocodone—Asthenia—Dactinomycin—muscle cancer	0.00638	0.00638	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—muscle cancer	0.00631	0.00631	CcSEcCtD
Hydrocodone—Thrombocytopenia—Etoposide—muscle cancer	0.0063	0.0063	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Methotrexate—muscle cancer	0.0063	0.0063	CcSEcCtD
Hydrocodone—Body temperature increased—Vincristine—muscle cancer	0.00628	0.00628	CcSEcCtD
Hydrocodone—Abdominal pain—Vincristine—muscle cancer	0.00628	0.00628	CcSEcCtD
Hydrocodone—Skin disorder—Etoposide—muscle cancer	0.00625	0.00625	CcSEcCtD
Hydrocodone—Hyperhidrosis—Etoposide—muscle cancer	0.00622	0.00622	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—muscle cancer	0.00618	0.00618	CcSEcCtD
Hydrocodone—Drowsiness—Methotrexate—muscle cancer	0.00604	0.00604	CcSEcCtD
Hydrocodone—Hypotension—Etoposide—muscle cancer	0.00601	0.00601	CcSEcCtD
Hydrocodone—Hypersensitivity—Vincristine—muscle cancer	0.00585	0.00585	CcSEcCtD
Hydrocodone—Paraesthesia—Etoposide—muscle cancer	0.00577	0.00577	CcSEcCtD
Hydrocodone—Dyspnoea—Etoposide—muscle cancer	0.00573	0.00573	CcSEcCtD
Hydrocodone—Somnolence—Etoposide—muscle cancer	0.00572	0.00572	CcSEcCtD
Hydrocodone—Asthenia—Vincristine—muscle cancer	0.0057	0.0057	CcSEcCtD
Hydrocodone—Vomiting—Dactinomycin—muscle cancer	0.00565	0.00565	CcSEcCtD
Hydrocodone—Agranulocytosis—Methotrexate—muscle cancer	0.00564	0.00564	CcSEcCtD
Hydrocodone—Rash—Dactinomycin—muscle cancer	0.0056	0.0056	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Etoposide—muscle cancer	0.00555	0.00555	CcSEcCtD
Hydrocodone—Fatigue—Etoposide—muscle cancer	0.00554	0.00554	CcSEcCtD
Hydrocodone—Constipation—Etoposide—muscle cancer	0.0055	0.0055	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00545	0.00545	CcSEcCtD
Hydrocodone—Nausea—Dactinomycin—muscle cancer	0.00528	0.00528	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Etoposide—muscle cancer	0.00526	0.00526	CcSEcCtD
Hydrocodone—Dizziness—Vincristine—muscle cancer	0.00525	0.00525	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—muscle cancer	0.00523	0.00523	CcSEcCtD
Hydrocodone—Abdominal pain—Etoposide—muscle cancer	0.00508	0.00508	CcSEcCtD
Hydrocodone—Body temperature increased—Etoposide—muscle cancer	0.00508	0.00508	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—muscle cancer	0.00508	0.00508	CcSEcCtD
Hydrocodone—Vomiting—Vincristine—muscle cancer	0.00505	0.00505	CcSEcCtD
Hydrocodone—Rash—Vincristine—muscle cancer	0.00501	0.00501	CcSEcCtD
Hydrocodone—Dermatitis—Vincristine—muscle cancer	0.005	0.005	CcSEcCtD
Hydrocodone—Headache—Vincristine—muscle cancer	0.00497	0.00497	CcSEcCtD
Hydrocodone—Angiopathy—Methotrexate—muscle cancer	0.00492	0.00492	CcSEcCtD
Hydrocodone—Mediastinal disorder—Methotrexate—muscle cancer	0.00489	0.00489	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—muscle cancer	0.00488	0.00488	CcSEcCtD
Hydrocodone—Mental disorder—Methotrexate—muscle cancer	0.00475	0.00475	CcSEcCtD
Hydrocodone—Hypersensitivity—Etoposide—muscle cancer	0.00474	0.00474	CcSEcCtD
Hydrocodone—Malnutrition—Methotrexate—muscle cancer	0.00472	0.00472	CcSEcCtD
Hydrocodone—Nausea—Vincristine—muscle cancer	0.00472	0.00472	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—muscle cancer	0.00462	0.00462	CcSEcCtD
Hydrocodone—Asthenia—Etoposide—muscle cancer	0.00461	0.00461	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—muscle cancer	0.00461	0.00461	CcSEcCtD
Hydrocodone—Back pain—Methotrexate—muscle cancer	0.00457	0.00457	CcSEcCtD
Hydrocodone—Pruritus—Etoposide—muscle cancer	0.00455	0.00455	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—muscle cancer	0.00426	0.00426	CcSEcCtD
Hydrocodone—Dizziness—Etoposide—muscle cancer	0.00425	0.00425	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—muscle cancer	0.00423	0.00423	CcSEcCtD
Hydrocodone—Cough—Methotrexate—muscle cancer	0.00412	0.00412	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—muscle cancer	0.00411	0.00411	CcSEcCtD
Hydrocodone—Convulsion—Methotrexate—muscle cancer	0.00409	0.00409	CcSEcCtD
Hydrocodone—Vomiting—Etoposide—muscle cancer	0.00409	0.00409	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—muscle cancer	0.00409	0.00409	CcSEcCtD
Hydrocodone—Rash—Etoposide—muscle cancer	0.00405	0.00405	CcSEcCtD
Hydrocodone—Dermatitis—Etoposide—muscle cancer	0.00405	0.00405	CcSEcCtD
Hydrocodone—Headache—Etoposide—muscle cancer	0.00403	0.00403	CcSEcCtD
Hydrocodone—Arthralgia—Methotrexate—muscle cancer	0.00402	0.00402	CcSEcCtD
Hydrocodone—Myalgia—Methotrexate—muscle cancer	0.00402	0.00402	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00399	0.00399	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—muscle cancer	0.00395	0.00395	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—muscle cancer	0.00393	0.00393	CcSEcCtD
Hydrocodone—Nausea—Etoposide—muscle cancer	0.00382	0.00382	CcSEcCtD
Hydrocodone—Nervous system disorder—Methotrexate—muscle cancer	0.00378	0.00378	CcSEcCtD
Hydrocodone—Thrombocytopenia—Methotrexate—muscle cancer	0.00377	0.00377	CcSEcCtD
Hydrocodone—Skin disorder—Methotrexate—muscle cancer	0.00374	0.00374	CcSEcCtD
Hydrocodone—Hyperhidrosis—Methotrexate—muscle cancer	0.00372	0.00372	CcSEcCtD
Hydrocodone—Hypotension—Methotrexate—muscle cancer	0.0036	0.0036	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—muscle cancer	0.00357	0.00357	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—muscle cancer	0.00354	0.00354	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00351	0.00351	CcSEcCtD
Hydrocodone—Insomnia—Methotrexate—muscle cancer	0.00348	0.00348	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—muscle cancer	0.00347	0.00347	CcSEcCtD
Hydrocodone—Paraesthesia—Methotrexate—muscle cancer	0.00346	0.00346	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00346	0.00346	CcSEcCtD
Hydrocodone—Dyspnoea—Methotrexate—muscle cancer	0.00343	0.00343	CcSEcCtD
Hydrocodone—Somnolence—Methotrexate—muscle cancer	0.00342	0.00342	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—muscle cancer	0.0034	0.0034	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00333	0.00333	CcSEcCtD
Hydrocodone—Fatigue—Methotrexate—muscle cancer	0.00332	0.00332	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—muscle cancer	0.00327	0.00327	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—muscle cancer	0.00327	0.00327	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—muscle cancer	0.00324	0.00324	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—muscle cancer	0.00322	0.00322	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Methotrexate—muscle cancer	0.00315	0.00315	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—muscle cancer	0.00312	0.00312	CcSEcCtD
Hydrocodone—Abdominal pain—Methotrexate—muscle cancer	0.00305	0.00305	CcSEcCtD
Hydrocodone—Body temperature increased—Methotrexate—muscle cancer	0.00305	0.00305	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00304	0.00304	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—muscle cancer	0.00302	0.00302	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—muscle cancer	0.003	0.003	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—muscle cancer	0.00297	0.00297	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—muscle cancer	0.00297	0.00297	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—muscle cancer	0.00285	0.00285	CcSEcCtD
Hydrocodone—Hypersensitivity—Methotrexate—muscle cancer	0.00284	0.00284	CcSEcCtD
Hydrocodone—Asthenia—Methotrexate—muscle cancer	0.00276	0.00276	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00273	0.00273	CcSEcCtD
Hydrocodone—Pruritus—Methotrexate—muscle cancer	0.00273	0.00273	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—muscle cancer	0.00264	0.00264	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—muscle cancer	0.00264	0.00264	CcSEcCtD
Hydrocodone—Dizziness—Methotrexate—muscle cancer	0.00255	0.00255	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—muscle cancer	0.00246	0.00246	CcSEcCtD
Hydrocodone—Vomiting—Methotrexate—muscle cancer	0.00245	0.00245	CcSEcCtD
Hydrocodone—Rash—Methotrexate—muscle cancer	0.00243	0.00243	CcSEcCtD
Hydrocodone—Dermatitis—Methotrexate—muscle cancer	0.00243	0.00243	CcSEcCtD
Hydrocodone—Headache—Methotrexate—muscle cancer	0.00241	0.00241	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—muscle cancer	0.00239	0.00239	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—muscle cancer	0.00236	0.00236	CcSEcCtD
Hydrocodone—Nausea—Methotrexate—muscle cancer	0.00229	0.00229	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—muscle cancer	0.00221	0.00221	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—muscle cancer	0.00198	0.00198	CcSEcCtD
